In esophageal squamous cell carcinoma (ESCC), the lncRNA PART1 was enriched in exosomes and it acted as a ceRNA of miR-129 to upregulate Bcl-2 and promote gefitinib resistance[87]. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.